$2.2B
Pharmaceutical Litigation
Case results are sourced directly from attorney websites by Injuria.ai's data infrastructure, which actively monitors 22,000+ personal injury law firms. They are not results obtained by ThatCarHitMe.com. Every case is unique and must be evaluated on its own facts. Prior results do not guarantee a similar outcome. The results shown are not necessarily representative of all results obtained by these firms.
Case Details
Johnson & Johnson fined for promoting the antipsychotic medication Risperdal for off-label use in treatment of nursing home residents with dementia, leading to civil and criminal penalties.
Additional Notes
The firm states they have represented many nursing home residents injured or deceased due to over-medication, implying this case highlights the type of issues they address. The promotion of this drug for non-approved use placed many elderly nursing home residents at risk for strokes and development of diabetes. Source: U.S. Department of Justice.